MIR - Medical International Research S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MIR - Medical International Research S.p.A. - overview
Established
1993
Location
Rome, -, Italy
Primary Industry
Medical Devices & Equipment
About
MIR - Medical International Research S. p. A. is an Italian company specializing in advanced medical devices for spirometry and oximetry, enhancing respiratory health management for healthcare professionals and patients across the globe.
Founded in 1993 and headquartered in Rome, Italy, MIR - Medical International Research S. p. A. focuses on the development of medical devices that aid in respiratory health monitoring.
The company has undergone strategic realignment to enhance its global presence and recently completed a significant acquisition in January 2025 when Quadrivio Group fully acquired MIR from Aksia and Overseas Industries. Financial terms of the deal remain undisclosed. MIR specializes in the development and distribution of advanced medical devices focused on spirometry and oximetry, primarily targeting healthcare professionals and patients within the pneumology sector. Their core product offerings include smartphone-compatible spirometers and oximeters, designed to be user-friendly and reliable for monitoring respiratory health in both clinical and home settings.
The products comply with global quality standards, having received various certifications, including FDA and NMPA. MIR serves a clientele across over 100 countries, encompassing healthcare providers, hospitals, and individual patients requiring effective respiratory management solutions. In 2023, MIR reported a revenue of USD 17. 20 mn and an EBITDA of USD 6.
10 mn. The company generates revenue through direct sales and subscription-based models, offering flagship products like the MIR Spiro series that integrates advanced software compatible with electronic medical records (EMR) systems, ensuring a streamlined distribution network. Looking ahead, MIR intends to leverage its recent acquisition to strengthen its global footprint and seek targeted acquisitions to expand its market reach. The company is working on the launch of new product lines designed to enhance user engagement and is strategizing entry into new markets by 2025.
The funding from the recent acquisition will facilitate these initiatives, enabling MIR to enhance its product offerings and broaden its geographical presence.
Current Investors
Aksia
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Diagnostic Equipment, Medical Equipment Distributors, Monitoring Equipment, Medical Software
Website
www.spirometry.com
Verticals
HealthTech, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
MIR - Medical International Research S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | MIR - Medical International Research S.p.A. | - | ||||||||
| Buyout | Completed | MIR - Medical International Research S.p.A. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.